Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Dovernet, Teaching Note
Simons, Robert L.; Kindred, NatalieNota del Instructor HBS-113011-EContabilidad y controlTeaching Note for 112061.Desde 0,00 €
-
PAREXEL International Corp.: Stages of Innovation, Teaching Note
Herzlinger, Regina E.; Kindred, NatalieNota del Instructor HBS-312057-ETeaching Note for 311-068 and 311-087.Desde 0,00 €
-
Naturhouse - Teaching Note
Mitchell, Jordan; Velamuri, RamaNota del Instructor ET-4-EIniciativa emprendedoraNote prepared as an aid to instructors in the classroom use of case E-65-E Naturhouse.Desde 0,00 €
-
Econet Wireless Zimbabwe - Teaching Note
Mitchell, Jordan; Velamuri, RamaNota del Instructor ET-2-EIniciativa emprendedoraNote prepared as an aid to instructors in the classroom use of cases E-62-E, E-63-E and E-66-E (Econet Wireless Zimbabwe A, B, C).Desde 0,00 €
-
Infosys Technologies: Powered by Intellect, Driven by Values - Teaching Note
Mitchell, Jordan; Velamuri, RamaNota del Instructor ET-5-EÉtica empresarial y Responsabilidad Social Corporativa, Iniciativa emprendedoraThis teaching note was made as an aid in class for case E-81-E: Infosys Technologies: Powered by Intellect, Driven by Values.Desde 0,00 €
-
Dovernet
Simons, Robert L.; Kindred, NatalieCaso HBS-112061-EContabilidad y controlThis case illustrates the implications of using stringent performance measurement systems to create performance pressure, motivate employee achievement, and sharpen a firm's competitiveness. It opens by describing the downsides of the ruthlessly competitiDesde 8,20 €
-
Merck: Managing Vioxx (A)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCaso HBS-109080-EConocimiento y comunicaciónThis two-class case series allows students to stand in the shoes of CEO Ray Gilmartin during the unfolding stages of a reputational crisis. Merck's mission statement claims to "put patients first," but the company is widely criticized for putting profit bDesde 8,20 €